Flagship explainer
How AMNEAL PHARMACEUTICALS, INC. makes its money
Start with a dollar of revenue and follow what the filing says remains.
Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.
| Filed line | Value | % of revenue | Source |
|---|---|---|---|
| $3.0B | 100% |
| |
| Cost of revenue | $1.9B | 63% |
|
| $1.1B | 37% |
| |
| $394M | 13% |
| |
| Income before tax | $139M | 5% |
|
| Income tax | $11.3M | 0% |
|
| $72.1M | 2% |
|
Source:
- SEC filing · FY 2025Filing detailsAccession 0001723128-26-000011